FGL1
protein-codingfibrinogen like 1, the group of Fibrinogen C domain containing
Gene summary
Fibrinogen-like 1 is a member of the fibrinogen family. This protein is homologous to the carboxy terminus of the fibrinogen beta- and gamma- subunits which contains the four conserved cysteines of fibrinogens and fibrinogen related proteins. However, this protein lacks the platelet-binding site, cross-linking region and a thrombin-sensitive site which are necessary for fibrin clot formation. This protein may play a role in the development of hepatocellular carcinomas. Four alternatively spliced transcript variants encoding the same protein exist for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~46.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FGL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004467.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 81 | 2 | 3 | 86 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 82 | 2 | 4 | 88 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004458.3 | 7 | MANE Select | |
| Ensembl | ENSP00000401952.1 | 7 | MANE Select | |
| RefSeq | NP_671736.2 | 7 | Standard | |
| RefSeq | NP_963846.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Cellular Component
- fibrinogen complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000398056
- Coding exons
- 7
- Length
- 45986
- Individuals with no LoFs
- 124191
- Homozygous LoFs
- 25
- Heterozygous LoFs
- 1528
- Defined
- 125744
- p
- 0.00619
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -2.72 | 266 | 167 | 1.59 | 0.00000861 | 2082 |
| Missense (PolyPhen) | 102 | 62.473 | 1.6327 | 783 | ||
| Synonymous | -4.54 | 104 | 59.4 | 1.75 | 0.00000324 | 524 |
| Loss of Function | -2.43 | 31 | 19.4 | 1.60 | 9.27e-7 | 216 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0011 | 0.0010 | notable |
| Latino/Admixed American | 0.0065 | 0.0061 | notable |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.013 | 0.012 | notable |
| Finnish | 0.039 | 0.038 | notable |
| European (Non-Finnish) | 0.0018 | 0.0017 | notable |
| South Asian | 0.0013 | 0.0012 | notable |
| Other | 0.0078 | 0.0075 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Has hepatocyte mitogenic activity.;
Intolerance Scores
- LoFtool
- 0.969
- RVIS EVS
- 1.29
- RVIS percentile EVS
- 93.88
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.000523
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |